Latest news with #NatcoPharma
Business Standard
11 hours ago
- Business
- Business Standard
Natco Pharma receives seven observations from USFDA Following Inspection at Kothur Facility
Natco Pharma announced that its pharmaceutical manufacturing facility in Kothur, Hyderabad, has received seven observations from the United States Food and Drug Administration (USFDA) following a recent inspection. In a regulatory filing, the company stated that the USFDA conducted the inspection from 9 June to 19 June 2025. At the conclusion of inspection, the USFDA has issued a Form 483 with seven observations. Natco Pharma expressed confidence in addressing the observations within the stipulated timeline and reaffirmed its commitment to current Good Manufacturing Practices (cGMP) and the consistent supply of high-quality pharmaceutical products to global markets. NATCO Pharma, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. The companys consolidated net profit increased 5.3% to Rs 406.60 crore on a 14.3% jump in revenue from operations to Rs 1,221 crore in Q4 FY25 over Q4 FY24. The counter shed 0.98% to Rs 872.75 on the BSE.
Business Standard
12 hours ago
- Business
- Business Standard
Nifty climbs above 25,000 level; realty shares advance
The key domestic indices traded with significant gains in morning trade, showing resilience in the face of escalating tensions between Israel and Iran. Market sentiment, however, remains sensitive to global cues, including crude oil prices and other international developments. The Nifty traded above the 25,000 level and Sensex crossed 82,150 mark. Realty shares jumped after declining in the past three trading sessions. At 10:30 IST, the barometer index, the S&P BSE Sensex advanced 816.02 points or 1% to 82,176.13. The Nifty 50 index jumped 232.45 points or 94% to 25,015. In the broader market, the S&P BSE Mid-Cap index fell 0.65% and the S&P BSE Small-Cap index shed 0.54%. The market breadth was strong. On the BSE, 2,271 shares rose and 1,203 shares fell. A total of 183 shares were unchanged. IPO Listing: Shares of Oswal Pumps were currently trading at Rs 641.20 at 10:14 IST on the BSE, representing a premium of 4.43% compared with the issue price of Rs 614. The scrip was listed at 632, exhibiting a premium of 2.93% to the issue price. So far, the stock has hit a high of 646.25 and a low of 625.20. On the BSE, over 6.96 lakh shares of the company were traded in the counter so far. Buzzing Index: The Nifty Realty index advanced 1.26% to 1,005.30. The index declined 2.7% in the past three trading sessions. Macrotech Developers (up 1.8%), Godrej Properties (up 1.54%), Brigade Enterprises (up 1.47%), Phoenix Mills (up 1.06%), Prestige Estates Projects (up 1.01%), Anant Raj (up 0.66%), Oberoi Realty (up 0.62%), Sobha (up 0.37%) and DLF (up 0.19%) advanced. Stocks in Spotlight: TD Power Systems rose 1.10% after the company secured an order worth Rs 67 crore from a leading multinational corporation for the supply of components for traction motors meant for export. ITD Cementation India declined 1.68%. The company announced that it has secured two major contracts cumulatively valued at approximately Rs 960 crore, excluding GST. Natco Pharma shed 0.68%. Natco Pharma announced that its pharmaceutical manufacturing facility in Kothur, Hyderabad, has received seven observations from the United States Food and Drug Administration (USFDA) following a recent inspection.
News18
15 hours ago
- Business
- News18
Stocks To Watch: Nestle, Oswal Pumps, Ethos, Natco Pharma, Angle One, And Others
Last Updated: Stocks to watch: Shares of firms like Nestle, Oswal Pumps, Ethos, Natco Pharma, Angle One, and others will be in focus on Friday's trade Stocks to Watch on June 20, 2025: Markets closed flat on the weekly expiry day amid mixed global cues, and stock-specific developments are expected to drive momentum today. Here's a look at key stocks likely to be in focus: Oswal Pumps The spotlight will be on Oswal Pumps as the company is set to debut on the exchanges today. Nestle India Nestle India has announced a board meeting scheduled for June 26 to consider a proposal for issuing bonus shares. Ethos Goldman Sachs sold over 1.77 lakh shares of Ethos in a block deal worth Rs 48 crore, with shares sold at Rs 2,700.6 apiece. Sai Life Sciences Private equity firm TPG is likely to offload 12.5 million shares, representing a 6% stake in Sai Life Sciences, in a deal estimated at $102 million (Rs 885 crore). The USFDA has issued Form 483 with seven observations for Natco Pharma's Kothur, Hyderabad facility. Axiscades Technologies Axiscades Technologies entered into a strategic partnership with Europe's Aldoria to enhance India's space capabilities. Angel One Devender Kumar, Chief Revenue Officer – Direct Business, has resigned and will be relieved from his duties effective September 30, 2025. Disclaimer:Disclaimer: The views and investment tips by experts in this report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions. First Published: June 20, 2025, 07:55 IST
Time of India
17 hours ago
- Business
- Time of India
Stocks in news: Oswal Pumps, Nestle India, Angel One, Natco Pharma, Ethos
Markets traded lacklustre on the weekly expiry day and ended almost flat amid mixed cues. In today's trade, shares of Oswal Pumps , Nestle India , Angel One , Natco Pharma , Ethos among others will be in focus due to various news developments. Oswal Pumps Shares of Oswal Pumps will be in focus as the company will debut on the exchanges today. Nestle India FMCG major Nestle India will hold a board meeting on June 26 to consider and approve a proposal for issue of bonus shares. Ethos Goldman Sachs sold over 1.77 lakh shares of Ethos via a block deal. The deal size is worth Rs 48 crore and the shares were sold at a price of Rs 2700.6. Sai Life Sciences Global assets management company TPG is likely to sell 12.5 million shares representing 6% stake Sai Life Sciences at an estimated deal size of $102 million (Rs 885 crore). Live Events GMM Pfaudler GMM Pfaudler arm Pfaudler Normag Systems GmbH, Germany, bagged an order worth Rs 330 crore from a European-based customer. Kaynes Technology Kaynes Technology opened its qualified institutional placement (QIP) issue to raise up to Rs 1,600 crore, according to reports. Natco Pharma US FDA issued Form 483 with 7 observations for company's Kothur, Hyderabad-based Pharma Division. Axiscades Tech Axiscades Tech signed a strategic partnership with Europe's Aldoria to strengthen India's Space Capabilities Angel One Devender Kumar resigned as the Chief Revenue Officer-Direct Business of the company with effect from September 30.
The Hindu
a day ago
- Business
- The Hindu
U.S. FDA issues 7 observations to Natco Pharma's formulations unit in Hyderabad
The U.S. Food and Drug Administration (U.S. FDA) has issued seven observations to Natco Pharma's formulations facility in Kothur, Hyderabad. The facility was inspected by the U.S. FDA from June 9-19. On conclusion, the company received seven observations in Form-483, Natco Pharma said on Thursday. The company said it is confident of addressing the observations within the stipulated timeline. 'The company remains committed to being cGMP compliant and in supplying high-quality products to its customers and patients globally,' Natco Pharma said. The U.S. FDA had in April 2024 issued a warning letter to the facility while raising quality concerns. The action followed an inspection and issue of eight observations in October 2023 by the regulator. The company then said the move may result in delay or withholding of pending product approvals from the site. The facility is for oral solid dosages, including cytotoxic orals; cytotoxic injectables; and pre filled syringes. The focus product categories are oncology, gastroenterology, central nervous system and cardiology. EOM
